SPP1 and myeloid sarcoma: Through its modulation of T cell activity and enhancement of cytokine production, OPN not only amplifies inflammatory responses but also supports the survival and persistence of autoreactive T cells, thereby exacerbating MS pathology and accelerating neurodegeneration.